Ferrario M, Merlini P A, Lucreziotti S, Poli A, Cantù F, Gobbi G, Bramucci E, Mussini A, Ardissino D
Divisione di Cardiologia, IRCCS Policlinico S. Matteo, Pavia, Italy.
Int J Cardiol. 1999 Apr 10;68 Suppl 1:S63-71. doi: 10.1016/s0167-5273(98)00293-9.
Unstable angina and non-Q-wave myocardial infarction still represent an unsolved problem for clinicians, owing to their unpredictable evolution and high incidence of coronary events in the follow-up. Traditional antithrombotic agents, unfractionated heparin and aspirin, have been proved to be highly effective, but show some important limitations. New potent antithrombotic therapy have been studied to improve their efficacy, with encouraging results. Among these drugs, low molecular weight heparins (for subcutaneous administration) and inhibitors of platelet glycoprotein receptor IIb/IIIa (for intravenous, and possibly oral, administration) are the most promising and are now under extensive investigation.
